Extensive evidence suggests that the canonical ALK5/Smad3 pathway is critically involved in EMT and the pathogenesis of fibrosis in many tissues [13], and inhibition of ALK5 with small-molecule LY2157299 (Galunisertib) showed reduced tumor metastasis in the mouse xenograft model [14]. This evidence concerns the gene TGFBR1 and neoplasm.